Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.61% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTSS
1726
DELISTED
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
| $1.99M | ﹤0.01% |
576,500
+45,400
| +9% | +$167K |
|
|
DRD
1727
DRDGold
DRD
$2.09B
| $1.99M | ﹤0.01% |
669,270
+52,000
| +8% | +$157K |
|
|
EARN
1728
Ellington Residential Mortgage REIT
EARN
$165M
| $1.99M | ﹤0.01% |
116,624
-16,611
| -12% | -$282K |
|
1729
Simpson Manufacturing
SSD
$7.91B
| $1.99M | ﹤0.01% |
54,600
+7,000
| +15% | +$238K |
|
1730
UMB Financial
UMBF
$11.5B
| $1.98M | ﹤0.01% |
+31,300
| New | +$1.87M |
|
1731
Wabash National
WNC
$510M
| $1.98M | ﹤0.01% |
139,200
-150,442
| -52% | -$2.06M |
|
1732
Cheniere Energy
CQP
$33.3B
| $1.98M | ﹤0.01% |
60,000
-123,800
| -67% | -$4.04M |
|
|
CVGW
1733
DELISTED
Calavo Growers
CVGW
| $1.98M | ﹤0.01% |
58,600
-14,200
| -20% | -$464K |
|
|
LDR
1734
DELISTED
Landauer Inc
LDR
| $1.98M | ﹤0.01% |
47,200
-18,910
| -29% | -$850K |
|
|
ARX
1735
DELISTED
Aeroflex Holding Corp (DE)
ARX
| $1.97M | ﹤0.01% |
187,900
+88,583
| +89% | +$818K |
|
|
QLIK
1736
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $1.97M | ﹤0.01% |
+87,100
| New | +$2M |
|
|
TRR
1737
DELISTED
Trc Companies
TRR
| $1.96M | ﹤0.01% |
315,748
+54,048
| +21% | +$299K |
|
1738
Blackstone
BX
$109B
| $1.96M | ﹤0.01% |
+59,815
| New | +$1.85M |
|
1739
Waters Corp
WAT
$40.5B
| $1.96M | ﹤0.01% |
18,800
-102,217
| -84% | -$10.8M |
|
1740
Arbutus Biopharma
ABUS
$924M
| $1.96M | ﹤0.01% |
150,200
+125,200
| +501% | +$1.78M |
|
1741
Allient
ALNT
$1.88B
| $1.96M | ﹤0.01% |
203,100
+120,300
| +145% | +$1.06M |
|
1742
Gerdau
GGB
$9.3B
| $1.96M | ﹤0.01% |
418,194
-1,335,852
| -76% | -$6.55M |
|
1743
Pampa Energía
PAM
$4.23B
| $1.96M | ﹤0.01% |
199,500
+103,000
| +107% | +$808K |
|
|
RFP
1744
DELISTED
Resolute Forest Products Inc.
RFP
| $1.95M | ﹤0.01% |
+116,300
| New | +$1.92M |
|
1745
Perion Network
PERI
$386M
| $1.95M | ﹤0.01% |
64,336
+5,369
| +9% | +$168K |
|
|
CTIC
1746
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.95M | ﹤0.01% |
+69,265
| New | +$2.08M |
|
1747
Astronics
ATRO
$4.61B
| $1.94M | ﹤0.01% |
75,338
-75,557
| -50% | -$1.96M |
|
|
IBTX
1748
DELISTED
Independent Bank Group, Inc.
IBTX
| $1.94M | ﹤0.01% |
34,846
+20,846
| +149% | +$1.1M |
|
|
METR
1749
DELISTED
METRO BANCORP, INC COMMON STOCK
METR
| $1.93M | ﹤0.01% |
83,327
+19,813
| +31% | +$424K |
|
1750
Camden National
CAC
$996M
| $1.93M | ﹤0.01% |
74,550
-8,550
| -10% | -$217K |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.